Pitt Pediatrics congratulates Silva Arslanian, MD, for being named a recipient of the 2023 Outstanding Achievement in Clinical Diabetes Research Award by the American Diabetes Association (ADA). This prestigious award is part of the annual National Scientific and Healthcare Achievement Awards from the ADA, which honor academics, health care providers, and educators who have contributed to substantial advances in the field of diabetes care and research.
Rarely awarded to providers of care in pediatric populations, Arslanian’s award recognizes her exceptional contributions in patient-oriented clinical research that have had a significant impact on diabetes prevention and treatment. The ADA specifically credits her work as considerably expanding knowledge of the “pathophysiological mechanisms of youth-onset type 2 diabetes, the rapid deterioration in β-cell function, and the impaired incretin effect through detailed investigations of insulin sensitivity and β-cell function during childhood growth and development in health and disease.”
Arslanian’s research has directly led to major changes in national and international clinical practice guidelines for youth-onset type 2 diabetes, and transformed the level of care many have received.
Arslanian and other awardees will be formally recognized at the ADA’s 83rd Scientific Sessions, to be held in San Diego in the summer.
To read more about Arslanian’s work, visit the Center for Pediatric Research in Obesity and Metabolism website.